Total Payments
$48,074
2024 Payments
$26,153
Companies
6
Transactions
42
Medicare Patients
807
Medicare Billing
$144,948
Payment Breakdown by Category
Consulting$19,846 (41.3%)
Travel$15,059 (31.3%)
Other$11,793 (24.5%)
Food & Beverage$1,362 (2.8%)
Education$13.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,846 | 6 | 41.3% |
| Travel and Lodging | $15,059 | 10 | 31.3% |
| Honoraria | $8,607 | 2 | 17.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,186 | 1 | 6.6% |
| Food and Beverage | $1,362 | 22 | 2.8% |
| Education | $13.89 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $28,862 | 34 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $19,017 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $99.19 | 1 | $0 (2023) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $38.34 | 1 | $0 (2018) |
| Retrophin, Inc. | $32.10 | 1 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $24.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,153 | 14 | Pharmacosmos Therapeutics Inc. ($14,075) |
| 2023 | $415.91 | 4 | Amgen Inc. ($316.72) |
| 2022 | $3,186 | 1 | Amgen Inc. ($3,186) |
| 2021 | $4,943 | 2 | Pharmacosmos Therapeutics Inc. ($4,943) |
| 2020 | $41.37 | 2 | Amgen Inc. ($41.37) |
| 2019 | $32.10 | 1 | Retrophin, Inc. ($32.10) |
| 2018 | $12,859 | 12 | Amgen Inc. ($12,821) |
| 2017 | $443.37 | 6 | Amgen Inc. ($443.37) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Nephrology | ||||||
| 10/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $43.30 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/25/2024 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $49.20 | General |
| Category: Nephrology | ||||||
| 10/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Honoraria | In-kind items and services | $5,607.00 | General |
| Category: HEMATOLOGY | ||||||
| 09/26/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Travel and Lodging | In-kind items and services | $8,467.50 | General |
| Category: HEMATOLOGY | ||||||
| 08/07/2024 | Amgen Inc. | EVENITY (Biological) | Consulting Fee | Cash or cash equivalent | $3,451.50 | General |
| Category: Bone Health | ||||||
| 08/07/2024 | Amgen Inc. | Prolia (Biological) | Consulting Fee | Cash or cash equivalent | $3,451.50 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Travel and Lodging | In-kind items and services | $4,027.94 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Travel and Lodging | In-kind items and services | $500.89 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Travel and Lodging | In-kind items and services | $215.18 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $101.53 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $57.12 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $48.90 | General |
| Category: Bone Health | ||||||
| 04/16/2024 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $106.74 | General |
| Category: Nephrology | ||||||
| 11/02/2023 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $147.50 | General |
| Category: Nephrology | ||||||
| 10/12/2023 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $127.62 | General |
| 09/29/2023 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $41.60 | General |
| Category: Nephrology | ||||||
| 06/29/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $99.19 | General |
| 12/07/2022 | Amgen Inc. | Prolia (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,186.00 | General |
| Category: Bone Health | ||||||
| 06/10/2021 | Pharmacosmos Therapeutics Inc. | Monoferric (Drug) | Consulting Fee | Cash or cash equivalent | $1,942.50 | General |
| Category: Hematology | ||||||
| 03/26/2021 | Pharmacosmos Therapeutics Inc. | Monoferric (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Hematology | ||||||
| 10/27/2020 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 01/08/2020 | Amgen Inc. | EVENITY (Biological), Parsabiv | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Bone Health | ||||||
| 11/09/2019 | Retrophin, Inc. | — | Food and Beverage | In-kind items and services | $32.10 | General |
| 10/30/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 141 | 206 | $128,630 | $27,033 |
| 2022 | 7 | 195 | 323 | $196,830 | $39,733 |
| 2021 | 9 | 252 | 406 | $194,740 | $43,274 |
| 2020 | 9 | 219 | 329 | $159,115 | $34,907 |
Total Patients
807
Total Services
1,264
Medicare Billing
$144,948
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 80 | $59,200 | $12,861 | 21.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 44 | $44,360 | $8,607 | 19.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 35 | $10,150 | $2,526 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 16 | $8,480 | $1,560 | 18.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $5,940 | $1,311 | 22.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 20 | $500.00 | $168.00 | 33.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 31 | 95 | $95,000 | $18,944 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 75 | $39,750 | $7,169 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 33 | $24,420 | $5,136 | 21.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 67 | $19,430 | $4,341 | 22.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $10,400 | $2,330 | 22.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 19 | $7,410 | $1,751 | 23.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 21 | $420.00 | $62.19 | 14.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 20 | 70 | $70,000 | $14,480 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 79 | $37,870 | $9,021 | 23.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 58 | 112 | $32,480 | $7,448 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 38 | $13,160 | $3,139 | 23.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $14,400 | $2,948 | 20.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 28 | $10,920 | $2,687 | 24.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $9,180 | $2,034 | 22.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 15 | 15 | $6,150 | $1,435 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 24 | 29 | $580.00 | $84.00 | 14.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 22 | 68 | $68,000 | $14,103 | 20.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 53 | $19,725 | $5,101 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 43 | 72 | $20,880 | $4,826 | 23.1% |
About Dr. Thomas Nickolas, MD
Dr. Thomas Nickolas, MD is a Nephrology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558438788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Nickolas, MD has received a total of $48,074 in payments from pharmaceutical and medical device companies, with $26,153 received in 2024. These payments were reported across 42 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($19,846).
As a Medicare-enrolled provider, Nickolas has provided services to 807 Medicare beneficiaries, totaling 1,264 services with total Medicare billing of $144,948. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Diabetes & Metabolism
- Location Saint Louis, MO
- Active Since 11/30/2006
- Last Updated 04/17/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1558438788
Products in Payments
- Prolia (Biological) $19,536
- MONOFERRIC (Drug) $14,075
- EVENITY (Biological) $8,431
- Monoferric (Drug) $4,943
- Parsabiv (Drug) $345.04
- Parsabiv (Biological) $48.22
- KRYSTEXXA (Biological) $43.30
- JYNARQUE (Drug) $38.34
- TARPEYO (Drug) $24.82
- Repatha (Biological) $3.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Saint Louis
Dr. Marcos Rothstein, Md, MD
Nephrology — Payments: $771,005
Nephrology $771,005
Dr. Daniel Coyne, Md, MD
Nephrology — Payments: $322,158
Nephrology $322,158
Dr. Tarek Alhamad, Md, MD
Nephrology — Payments: $237,080
Nephrology $237,080
Dr. Anuja Java, Md, MD
Nephrology — Payments: $162,504
Nephrology $162,504
Krista Lentine, Md,Phd, MD,PHD
Nephrology — Payments: $90,028
Nephrology $90,028
Dr. Tingting Li, Md, MD
Nephrology — Payments: $61,262
Nephrology $61,262